F&P Healthcare FY25 guidance to be in the spotlight

F&P Healthcare FY25 guidance to be in the spotlight
F&P Healthcare expects its emerging anaesthesia business will continue to grow quickly. (Image: Fisher & Paykel Healthcare)
Rebecca Howard
Fisher & Paykel Healthcare’s guidance for the 2025 financial year will be of keen interest when it reports on May 29.“With FPH having pre-announced its FY24 result, the key question when FPH reports will be guidance for FY25,” said Craigs Investment Partners analysts Stephen Ridgewell and Rob Morrison.In early March the healthcare products manufacturer said it expected full-year operating revenue would be approximately $1.73 billion for the year to March 31.It forecast underlying profit after tax (excluding any fair v...

More Markets

Market edges higher as NZME lifts earnings guidance
Markets

Market edges higher as NZME lifts earnings guidance

The NZ sharemarket was up on Wednesday after a strong lead-in from the US.

Ebos CEO grilled on 'drastic' share-price fall
Markets

Ebos CEO grilled on 'drastic' share-price fall

Adam Hall's first AGM may well be the toughest he'll ever face.

RBNZ paying for unused floor space at new office
Property

RBNZ paying for unused floor space at new office

The Reserve Bank of NZ's plush new Britomart office will be only partially occupied. 

RBNZ cuts number of jobs by 20%
Finance

RBNZ cuts number of jobs by 20%

The Reserve Bank claims $11m of cost savings via Project Denby’s 20% job cuts.